Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Paula Mandall"'
Autor:
James P Wylie, Peter Hoskin, John P Logue, Peter D. Dickinson, David Bottomley, Paula Mandall, Ric Swindell, Jahangeer Malik
Publikováno v:
BJU International. 113:748-753
Objective To report the outcomes of >1000 men with low-risk prostate cancer treated with low-dose-rate (LDR) brachytherapy at three large UK cancer centres. Patients and Methods A total of 1038 patients with low-risk prostate cancer (prostate-specifi
Autor:
Carmel N Anandadas, Meriel P Burns, James P Wylie, Susan E Davidson, Paula Mandall, Jacqueline E Livsey, Damian J. J. Farnell, Jacqueline A Routledge, Catharine M L West, Ric Swindell, John P Logue
Publikováno v:
Radiotherapy and Oncology. 97:136-142
Purpose: To improve a questionnaire used to collect patient-reported outcomes from patients with early stage prostate cancer treated with brachytherapy. A secondary aim was to adapt the Late Effects of Normal Tissue (LENT) subjective toxicity questio
Autor:
Peter Ostler, Darren M Mitchell, James P Wylie, Peter Hoskin, Tony Elliott, Paula Mandall, Ann Henry, John P Logue, David Bottomley, Dan Ash
Publikováno v:
Clinical Oncology. 20:738-744
Aims To report the results of I 125 prostate brachytherapy from a central, prospectively collected database of three UK institutions. Materials and methods All patients treated with I 125 permanent prostate brachytherapy at the Christie Hospital, Man
Autor:
Susan E Davidson, Paula Mandall, Jahangeer Malik, Ananya Choudhury, John P Logue, Tony Elliott, Claire Arthur, Cathy M Taylor, James P Wylie, Jacqueline E Livsey, Nooreen Alam, Anna T Tran
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 26(10)
Aims High dose rate (HDR) brachytherapy offers a highly conformal approach to radiotherapy delivery, enabling dose escalation. We report our experience using a combined HDR boost and external beam radiotherapy (EBRT) approach and its associated toxic
Autor:
Peter D, Dickinson, Jahangeer, Malik, Paula, Mandall, Ric, Swindell, David, Bottomley, Peter, Hoskin, John P, Logue, James P, Wylie
Publikováno v:
BJU international. 113(5)
To report the outcomes of1000 men with low-risk prostate cancer treated with low-dose-rate (LDR) brachytherapy at three large UK cancer centres.A total of 1038 patients with low-risk prostate cancer (prostate-specific antigen [PSA] ≤10 ng/mL, Gleas
Autor:
James P Wylie, Ric Swindell, Paula Mandall, Peter Hoskin, David Bottomley, John P Logue, A. Tran
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 109(2)
Background and purpose Routine use of I-125 interstitial brachytherapy (BT) alone in intermediate risk (IR) prostate cancer is controversial. It is often combined with external beam radiotherapy (EBRT). The biochemical outcome of a large cohort of on
Autor:
R. Swindell, C. Arthur, Jacqueline E Livsey, P. Elliot, J. Malik, John P Logue, Paula Mandall, James D. Wylie, A. Tran, Ananya Choudhury
Publikováno v:
Radiotherapy and Oncology. 103:S92-S93
Publikováno v:
Clinical Oncology. 19:S50-S51
Publikováno v:
Clinical Oncology. 24:154
Multi-institutional Outcome Following LDR Brachytherapy in Patients with Higher Risk Prostate Cancer
Publikováno v:
Clinical Oncology. 24:155